Lipocine (LPCN) Retained Earnings (2016 - 2025)
Lipocine's Retained Earnings history spans 14 years, with the latest figure at -$207.0 million for Q3 2025.
- For Q3 2025, Retained Earnings fell 2.72% year-over-year to -$207.0 million; the TTM value through Sep 2025 reached -$207.0 million, down 2.72%, while the annual FY2024 figure was $9138.0, 100.0% up from the prior year.
- Retained Earnings reached -$207.0 million in Q3 2025 per LPCN's latest filing, down from -$203.8 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $9138.0 in Q4 2024 to a low of -$207.0 million in Q3 2025.
- Average Retained Earnings over 5 years is -$122.4 million, with a median of -$182.2 million recorded in 2021.
- Peak YoY movement for Retained Earnings: crashed 5298003.22% in 2022, then skyrocketed 100.0% in 2024.
- A 5-year view of Retained Earnings shows it stood at -$172.7 million in 2021, then skyrocketed by 99.99% to -$20321.0 in 2022, then tumbled by 983007.2% to -$199.8 million in 2023, then skyrocketed by 100.0% to $9138.0 in 2024, then plummeted by 2265653.55% to -$207.0 million in 2025.
- Per Business Quant, the three most recent readings for LPCN's Retained Earnings are -$207.0 million (Q3 2025), -$203.8 million (Q2 2025), and -$201.6 million (Q1 2025).